EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ultrasound-Based Therapies in Primary Central Nervous System Tumors

Giovanni Dima iD, Alessandro Olivari, Vincenzo Di Nunno, Marta Aprile, Alicia Tosoni, Lidia Gatto, Chiara Maria Argento, Marzia Margotti, Stefania Bartolini, Alfredo Conti iD, Enrico Franceschi

Cancers · 20.03.2026 · 18 (6) · 1010

DOI: 10.3390/cancers18061010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.03.2026. Verfasst von Giovanni Dima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nervous System Medical Oncology Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Delle Scienze Neurologiche di Bologn…. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary central nervous system (CNS) tumors remain a major challenge in neuro-oncology due to their cellular heterogeneity, infiltrative growth, and the protective blood–brain barrier (BBB), which limits the effectiveness of systemic therapies. Despite aggressive multimodal treatments, patient survival remains poor, highlighting the urgent need for new therapeutic strategies. Ultrasound-based therapies, including focused ultrasound (FUS) and sonodynamic therapy (SDT), have emerged as promising approaches. FUS can transiently open the BBB and induce localized mechanical and thermal effects, enhancing drug delivery, while SDT activates tumor-specific sensitizers to generate reactive oxygen species that trigger cancer cell death. Preclinical and early clinical studies suggest that combining these modalities with chemotherapy, immunotherapy, or radiotherapy may improve treatment outcomes. Emerging tools such as AI-guided monitoring, theranostic platforms, and ultrasound-responsive nanoparticles could further enable personalized interventions. However, challenges remain, including protocol variability, tumor heterogeneity, and limited long-term safety data. Careful optimization and clinical validation are needed before these strategies can be widely adopted in the management of CNS tumors.

Schlagwörter

Stichwörter der Autor:innen

AI-guided therapyCNS tumorsblood–brain barrierfocused ultrasoundmultimodal neuro-oncologynanotheranosticsreactive oxygen speciessonodynamic therapy

Autor:innen und Institutionen

  • Nervous System Medical Oncology Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Delle Scienze Neurologiche di Bologna, Bellaria Hospital, 40139 Bologna, Italy.
  • Medical Oncology Unit 2, Santa-Chiara Hospital, 56126 Pisa, Italy.
  • Medical Oncology Unit, Parma University Hospital, 43125 Parma, Italy.
  • Department of Neurosurgery, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
  • Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Alma Mater Studiorum Università di Bologna, 40126 Bologna, Italy.

ORCID-Profile: Giovanni Dima, Alfredo Conti

Zitieren

APA

Dima, G., Olivari, A., Di Nunno, V., Aprile, M., Tosoni, A., Gatto, L., Argento, C. M., Margotti, M., Bartolini, S., Conti, A., & Franceschi, E. (2026). Ultrasound-Based Therapies in Primary Central Nervous System Tumors. Cancers, 18(6), 1010. https://doi.org/10.3390/cancers18061010

Vancouver

Dima G, Olivari A, Di Nunno V, Aprile M, Tosoni A, Gatto L, et al. Ultrasound-Based Therapies in Primary Central Nervous System Tumors. Cancers. 2026;18(6):1010. doi:10.3390/cancers18061010

BibTeX
@article{Dima2026,
  author = {Dima, Giovanni and Olivari, Alessandro and Di Nunno, Vincenzo and Aprile, Marta and Tosoni, Alicia and Gatto, Lidia and Argento, Chiara Maria and Margotti, Marzia and Bartolini, Stefania and Conti, Alfredo and Franceschi, Enrico},
  title = {Ultrasound-Based Therapies in Primary Central Nervous System Tumors},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {1010},
  doi = {10.3390/cancers18061010}
}
Kostenlos starten →